N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction
- 1 June 2021
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 40 (6) , 447-457
Abstract
No abstract availableKeywords
Funding Information
- USF Health Morsani College of Medicine
- BWH
This publication has 49 references indexed in Scilit:
- Longitudinal analysis of the lung microbiome in lung transplantationFEMS Microbiology Letters, 2012
- Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human HepatocytesJournal of Virology, 2012
- Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharideBMC Medicine, 2012
- Analyses of the Microbial Diversity across the Human MicrobiomePLOS ONE, 2012
- Microbes-induced EMT at the crossroad of inflammation and cancerGut Microbes, 2012
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantationThorax, 2009
- Nmi (N‐Myc interactor) inhibits Wnt/β‐catenin signaling and retards tumor growthInternational Journal of Cancer, 2009
- Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?European Respiratory Journal, 2008
- Bronchiolitis Obliterans Syndrome Complicating Lung or Heart-Lung TransplantationSeminars in Respiratory and Critical Care Medicine, 2003